Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Novel grid combined with peripheral distortion correction for ultra-widefield image grading of age-related macular degeneration.

Oellers P, Laíns I, Mach S, Garas S, Kim IK, Vavvas DG, Miller JW, Husain D, Miller JB.

Clin Ophthalmol. 2017 Nov 8;11:1967-1974. doi: 10.2147/OPTH.S143246. eCollection 2017.

2.

Caffeine in the management of patients with headache.

Lipton RB, Diener HC, Robbins MS, Garas SY, Patel K.

J Headache Pain. 2017 Oct 24;18(1):107. doi: 10.1186/s10194-017-0806-2. Review.

3.

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.

4.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

5.

Choroidal Changes Associated With Subretinal Drusenoid Deposits in Age-related Macular Degeneration Using Swept-source Optical Coherence Tomography.

Laíns I, Wang J, Providência J, Mach S, Gil P, Gil J, Marques M, Armstrong G, Garas S, Barreto P, Kim IK, Vavvas DG, Miller JW, Husain D, Silva R, Miller JB.

Am J Ophthalmol. 2017 Aug;180:55-63. doi: 10.1016/j.ajo.2017.05.021. Epub 2017 Jun 1.

PMID:
28579063
6.

Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection: A Systematic Review and Meta-Analysis.

Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, Bernick J, Leung E, Chih S, Wells G, Beanlands RS, Chow BJ.

Circ Cardiovasc Imaging. 2017 Apr;10(4). pii: e005772. doi: 10.1161/CIRCIMAGING.116.005772. Review.

7.

CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.

Stott SR, Hayat S, Carnwath T, Garas S, Sleeman JP, Barker RA.

PLoS One. 2017 Feb 9;12(2):e0171748. doi: 10.1371/journal.pone.0171748. eCollection 2017.

8.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

9.

Erratum. Correction to: Dopamine and Huntington's disease.

Schwab LC, Garas SN, Drouin-Ouellet J, Mason SL, Stott SR, Barker RA.

Expert Rev Neurother. 2015;15(11):1367. doi: 10.1586/14737175.2015.1088179. Epub 2015 Nov 2. No abstract available.

PMID:
26523752
10.

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.

Weisz G, Généreux P, Iñiguez A, Zurakowski A, Shechter M, Alexander KP, Dressler O, Osmukhina A, James S, Ohman EM, Ben-Yehuda O, Farzaneh-Far R, Stone GW; RIVER-PCI investigators.

Lancet. 2016 Jan 9;387(10014):136-45. doi: 10.1016/S0140-6736(15)00459-6. Epub 2015 Oct 22.

PMID:
26474810
11.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators.

N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12.

12.

Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidus.

Abdi A, Mallet N, Mohamed FY, Sharott A, Dodson PD, Nakamura KC, Suri S, Avery SV, Larvin JT, Garas FN, Garas SN, Vinciati F, Morin S, Bezard E, Baufreton J, Magill PJ.

J Neurosci. 2015 Apr 29;35(17):6667-88. doi: 10.1523/JNEUROSCI.4662-14.2015.

13.

Dopamine and Huntington's disease.

Schwab LC, Garas SN, Drouin-Ouellet J, Mason SL, Stott SR, Barker RA.

Expert Rev Neurother. 2015 Apr;15(4):445-58. doi: 10.1586/14737175.2015.1025383. Epub 2015 Mar 16. Review. Erratum in: Expert Rev Neurother. 2015;15(11):1367. Garas, Shaady N [corrected to Garas, Shady N].

PMID:
25773746
14.

Symptomatic Overlap and Therapeutic Opportunities in Primary Headache.

Cady R, Garas SY, Patel K, Peterson A, Wenzel R.

J Pharm Pract. 2015 Aug;28(4):413-8. doi: 10.1177/0897190014544799. Epub 2014 Aug 11. Review.

PMID:
25112305
15.

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.

16.

Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.

Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE, Marshall JJ, Leimbach M, Huber P, Garas S, Sammons BH, McCall SA, Petersen RJ, Bailey DE, Chu H, Mahoney EM, Weintraub WS, Guyton RA.

J Thorac Cardiovasc Surg. 2003 Apr;125(4):797-808.

17.

Overview of therapies for prevention of restenosis after coronary interventions.

Garas SM, Huber P, Scott NA.

Pharmacol Ther. 2001 Nov-Dec;92(2-3):165-78. Review.

PMID:
11916536
18.

Letter: Oral contraceptives and benign liver tumour.

Bartók I, Garas S, Szabó L.

Lancet. 1976 Feb 28;1(7957):479-10. No abstract available.

PMID:
55737

Supplemental Content

Loading ...
Support Center